Lupin launches generic Onfi
Lupin is introducing its generic Onfi (clobazam oral suspension) in a 2.5mg/mL. dosage strength. The company had previously received Food and Drug Administration approval.
The generic of Lundbeck’s branded drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years old or older.
Clobazam oral suspension had a market value of $253 million, according to IQVIA December 2018 data.
The generic of Lundbeck’s branded drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years old or older.
Clobazam oral suspension had a market value of $253 million, according to IQVIA December 2018 data.